Keywords: vioxx, launched, first, eu, market, marketing, battle
Vioxx launched in first EU market as marketing battle hots up
Article | 10 June 1999
Merck & Co has fired a broadside against rival companies Searle andPfizer with the announcement that its selective cyclo-oxygenase-2 inhibitor Vioxx ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
